Aurora Cannabis to Acquire Whistler Medical for $132 Million

Aurora Cannabis Inc. (NYSE: ACB) announced this week that the company has entered into a letter of intent to acquire Whistler Medical Marijuana Corp. Whistler Medical will be acquired for up to $132 million in ACB shares.

The acquisition of Whistler Medical, a cannabis company that is widely renowned for its organic cannabis cultivation practices, will bring the number of independent companies who were first given access to produce organic cannabis from 8 to 1. Whistler Medical is one of the eight organic cannabis corporations who were given first approval and were then dubbed with “blessed eight”. The last independent member of the blessed eight after the acquisition is completed will be Delta 9 Cannabis.

Chief Corporate Officer of Aurora Cannabis, Cam Battley, stated in a phone interview: “I would call [Whistler] the crown jewel of organic cannabis production worldwide. It’s the first organic-certified company, and now we’ve essentially got the market to ourselves.”

The blessed eight companies had a significant amount of time to grow a diverse portfolio of cannabis genetics, while competitors couldn’t even begin the process. Chief Executive Officer of Robes Cannabis, Maxim Zavet, stated: “They have been able to plant their flag and build a reputation in the medical cannabis industry and industry as a whole.”

Curious about other great cannabis companies? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Source

Aurora Cannabis to Acquire Whistler Medical for $132 Million

About Cannin.com: Your Marijuana Stocks Resource

Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.

Use Cannin as your resource for:

Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.

Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?

Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
108% Backtested since 2012

We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks

Aurora Cannabis to Acquire Whistler Medical for $132 Million